• Blog
  • Publications
  • News
  • Contact Us
Visit Us On FacebookVisit Us On Linkedin
  • Blog
  • Publications
  • News
  • Contact Us
Owen Barry Pharmeceuticals, epilepsy Owen Barry Pharmeceuticals, epilepsy
  • About
  • Matthew’s Story
  • The Team
    • Founders
      • Michael Poulter Ph.D.
      • John Poulter B.A., C.F.A.
    • Management
      • Lawrence Mahan Ph.D.
      • Michael Rogawski, MD, PhD
    • Board of Directors
      • John Poulter B.A., C.F.A.
      • Lawrence Mahan Ph.D.
      • Caroline Schild-Poulter, Ph.D.
      • Rod Prat B.A., M.B.A.
    • Scientific and Clinical Advisory
      • Pavel Klein, MD
      • Peter Carlen, MD, FRCPC
      • Anthony Krantis Ph.D.
      • Tony Durst Ph.D.
  • Technology
  • Investors
  • About
  • Matthew’s Story
  • The Team
    • Founders
      • Michael Poulter Ph.D.
      • John Poulter B.A., C.F.A.
    • Management
      • Lawrence Mahan Ph.D.
      • Michael Rogawski, MD, PhD
    • Board of Directors
      • John Poulter B.A., C.F.A.
      • Lawrence Mahan Ph.D.
      • Caroline Schild-Poulter, Ph.D.
      • Rod Prat B.A., M.B.A.
    • Scientific and Clinical Advisory
      • Pavel Klein, MD
      • Peter Carlen, MD, FRCPC
      • Anthony Krantis Ph.D.
      • Tony Durst Ph.D.
  • Technology
  • Investors
29 May 2025

Board Changes

by Larry Mahan | posted in: Uncategorized | 0

TORONTO, ONTARIO – May 28, 2025 – OB Pharmaceuticals, Inc. announces the retirement of two founding Board members, Andrew Clarke … Read More

Recent Posts

  • Board Changes
  • OB Pharmaceuticals announces its poster presentation at the annual meeting of the American Epilepsy Society
  • OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski
  • New Patents Awarded
  • Biotechnology Innovation Organization’s International Convention

Social Media

Visit Us On FacebookVisit Us On Linkedin

Site Designed By Wayland Robinson Design & Multimedia.

Posts

  • Disclaimer
  • Terms Of Use
  • Privacy Statement

Copyright 2021 O.B. Pharmaceuticals. All Rights Reserved.